However, if we considered patients with PSA below 4 ng/ml, the evaluation of the performance of PSA tests even with correction for verification bias (selective referral to biopsy of only screen-positive men) also must consider the time dimension since the last negative screen for interval cancer to avoid bias. The gene discussed is KLK3; the disease is cancer.